FindTrial
Sign In

The effect of low dose levothyroxine on the neurodevelopment of newborns with thyrotropin between 5 to 10 mU/L

The effect of low dose levothyroxine on the neurodevelopment of newborns with thyrotropin between 5 to 10 mU/L

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800019608
Enrollment
Unknown
Registered
2018-11-19
Start date
2018-11-30
Completion date
Unknown
Last updated
2018-11-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Newborns with thyrotropin between 5 to 10 mU/L

Interventions

Group 1:levothyroxine 12.5µg/d
Group 2:No use of levothyroxine

Sponsors

Peking University First Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Full-term infants monitored for thyroid function from one week to one month after birth; TSH 5~10mU/L.

Exclusion criteria

Exclusion criteria: with low level of FT3 and/or FT4; with severe brain damage,e.g. severe intracranial hemorrhage,hypoxic ischemic encephalopathy,serious heart disease.

Design outcomes

Primary

MeasureTime frame
MDI and PDI;—

Countries

China

Contacts

Public ContactGuoyu Sun

Peking University First Hospital

sunguoyu999@126.com+86 18614086075

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026